0001487371-20-000061.txt : 20200227
0001487371-20-000061.hdr.sgml : 20200227
20200227205355
ACCESSION NUMBER: 0001487371-20-000061
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200225
FILED AS OF DATE: 20200227
DATE AS OF CHANGE: 20200227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mitchell Brian Andrew
CENTRAL INDEX KEY: 0001707237
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34753
FILM NUMBER: 20665220
MAIL ADDRESS:
STREET 1: 5964 LA PLACE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92008
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GenMark Diagnostics, Inc.
CENTRAL INDEX KEY: 0001487371
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 272053069
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5964 LA PLACE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92008
BUSINESS PHONE: (760) 448-4300
MAIL ADDRESS:
STREET 1: 5964 LA PLACE COURT
CITY: CARLSBAD
STATE: CA
ZIP: 92008
4
1
wf-form4_158285481802160.xml
FORM 4
X0306
4
2020-02-25
0
0001487371
GenMark Diagnostics, Inc.
GNMK
0001707237
Mitchell Brian Andrew
5964 LA PLACE COURT
CARLSBAD
CA
92008
0
1
0
0
SVP, Operations
Common Stock
2020-02-25
4
A
0
33750
0
A
228132
D
Common Stock
2020-02-25
4
A
0
33750
0
A
261882
D
Common Stock
2020-02-25
4
S
0
232
3.81
D
261650
D
Market Stock Units
0.0
2020-02-25
4
A
0
22500
0
A
Common Stock
22500.0
22500
D
The amount reported reflects restricted stock units granted to the Reporting Person pursuant to the Issuer's 2010 Equity Incentive Plan. The restricted stock units vest 25% on February 25, 2021 and the remaining shares subject to such award vest in 12 equal quarterly installments thereafter.
The amount reported reflects restricted stock units granted to the Reporting Person pursuant to the Issuer's 2010 Equity Incentive Plan. The restricted stock units vest 50% on February 25, 2021 and the remaining shares subject to such award vest in 4 equal quarterly installments thereafter.
The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted restricted stock units.
Each market stock unit ("MSU") represents the contingent right to receive, following vesting, between 0% and 200% of one share of the Issuer's common stock, subject to the level of achievement of applicable performance conditions. The resulting number of shares acquired upon vesting of the MSUs, if any, is based on the Issuer's total shareholder return for each performance period as compared to the Nasdaq Composite Index.
The MSUs vest in three equal installments, on each of December 31, 2020, December 31, 2021, and December 31, 2022; provided that, at the end of the second and third performance periods, the Reporting Person is eligible to receive any shares that were not earned in the first and second performance periods to the extent that the Issuer's two-year or three-year total shareholder return, as applicable, exceeds the prior performance results as compared to the NASDAQ Composite Index.
/s/ Eric Stier, Attorney-in-fact
2020-02-27